SCHF - ETF AI Analysis

Top Page

Schwab International Equity ETF (SCHF)

Rating:63Neutral

Price Target:―

SCHF (Schwab International Equity ETF) has a solid overall rating, mainly because many of its largest holdings—like Novartis, AstraZeneca, HSBC, and Toyota—show strong financial health, positive earnings call sentiment, and generally supportive valuations, which together provide a stable foundation for the fund. This strength is somewhat offset by holdings such as Shell and Commonwealth Bank of Australia, where weaker technical trends, revenue or cash flow challenges, and leverage concerns introduce added risk. The main risk factor for SCHF is its exposure to individual companies facing valuation and technical pressures, which could create short-term volatility even though the overall portfolio remains broadly diversified internationally.

Positive Factors

Very Low Expense Ratio

The fund charges a very low fee, so more of the investment returns stay in investors’ pockets over time.

Broad International Diversification

Holdings spread across many countries such as Japan, the UK, Europe, and Canada help reduce the impact of problems in any single market.

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating supportive recent market conditions for its holdings.

Negative Factors

Heavy Financial Sector Exposure

A large portion of the portfolio is in financial companies, which can make the fund more sensitive to changes in interest rates and banking conditions.

Mixed Performance Among Top Holdings

While some leading positions have performed strongly, several major holdings have been weak, which can drag on overall returns.

Limited U.S. Market Focus

Because the ETF emphasizes international stocks and has relatively modest U.S. exposure, it may lag when U.S. markets are leading global performance.

SCHF vs. SPDR S&P 500 ETF (SPY)

AUM59.03B

RegionDeveloped Markets

Expense Ratio0.03%

Beta0.75

IssuerSchwab

Inception DateNov 03, 2009

Dividend Yield3.27%

Asset ClassEquity

Index TrackedFTSE All-World Developed x US

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume13,888,939

30 Day Avg. Volume12,704,767

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

28.26

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1315

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SCHF Summary

SCHF is the Schwab International Equity ETF, which follows the FTSE Developed ex US Index. It invests in many companies from developed countries outside the U.S., including Japan, the UK, and Europe. The fund holds well-known names like Toyota, Nestlé, and AstraZeneca, and spreads money across many sectors such as financials, industrials, and technology. Someone might invest in SCHF to diversify beyond U.S. stocks and seek long-term growth from global markets in a single, low-cost fund. A key risk is that international stocks can be volatile and can go up or down with global market and currency swings.

How much will it cost me?The Schwab International Equity ETF (SCHF) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because SCHF is passively managed, tracking an index rather than relying on active stock picking.

What would affect this ETF?The Schwab International Equity ETF (SCHF) could benefit from global economic growth, particularly in developed markets outside the U.S., as well as advancements in sectors like technology and healthcare, which are among its top holdings. However, it may face challenges from rising interest rates, currency fluctuations, or geopolitical tensions that could negatively impact international markets and sectors like financials and energy. Regulatory changes in key regions or slower growth in developed economies could also affect its performance.

SCHF Top 10 Holdings

SCHF leans heavily on a mix of European health care giants and global financials, with ASML acting as the star performer, its rising share price giving the fund a clear tech-powered tailwind. Roche, Novartis, and AstraZeneca are also climbing steadily, turning the health care sleeve into a key engine of growth. Big banks like HSBC, Royal Bank of Canada, and Mitsubishi UFJ are more of a slow-and-steady ballast than a rocket booster, while Nestlé and Toyota add stability. Overall, it’s a broadly diversified, developed-markets ex-U.S. play with no single stock dominating the story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	1.97%	$1.16B	€438.14B	72.70%	76 Outperform
ROG	Roche Holding AG	1.15%	$676.87M	CHF272.90B	26.73%	73 Outperform
NOVN	Novartis AG	1.12%	$656.80M	CHF234.59B	22.14%	80 Outperform
AZN	AstraZeneca	1.07%	$632.33M	$301.48B	20.11%	80 Outperform
HSBA	HSBC Holdings	1.06%	$626.57M	£213.83B	42.06%	80 Outperform
NESN	Nestlé SA	0.94%	$555.24M	CHF202.95B	0.58%	71 Outperform
SHEL	Shell (UK)	0.87%	$512.94M	£176.52B	22.65%	73 Outperform
7203	Toyota Motor	0.85%	$503.21M	¥45.81T	23.81%	80 Outperform
RY	Royal Bank Of Canada	0.85%	$499.25M	$228.95B	42.10%	75 Outperform
SAP	SAP SE	0.74%	$435.49M	€196.68B	-32.79%	66 Neutral

SCHF Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

25.53

Negative

100DMA

24.37

Positive

200DMA

23.06

Positive

Market Momentum

MACD

0.06

Positive

RSI

37.17

Neutral

STOCH

24.66

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 26.39, equal to the 50-day MA of 25.53, and equal to the 200-day MA of 23.06, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 37.17 is Neutral, neither overbought nor oversold. The STOCH value of 24.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SCHF.

SCHF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SCHF	―	―	$59.03B	0.03%	63 Neutral
VEA	―	―	$212.27B	0.03%	60 Neutral
SPDW	―	―	$37.61B	0.03%	62 Neutral
IDEV	―	―	$28.18B	0.04%	66 Neutral
DFAI	―	―	$14.85B	0.18%	64 Neutral
AVDE	―	―	$14.30B	0.23%	65 Neutral

Performance Comparison

SCHF

Schwab International Equity ETF

25.14

5.87

30.46%

VEA

Vanguard FTSE Developed Markets ETF

―

SPDW

SPDR Portfolio Developed World ex-US ETF

―

IDEV

iShares Core MSCI International Developed Markets ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

AVDE

Avantis International Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents